Preliminary data from its 3rd phase of clinical trials indicate that the domestically produced and government-backed Covaxin in India has an efficacy rate of 81%. The use of the Oxford-AstraZeneca vaccine, also known as Covishield, has also been approved in India.
Covishield vaccine in Tamil Nadu
During its clinical trial the vaccine has been injected to approximately 43,538 volunteers of different race, origin & Country., Among this only 10% of then acquired the disease, this becomes the great breakthrough news in this pandemic.
Covishield vaccine clinical trials in Tamil Nadu will start by the end of this month. Union Health Minister has praised in the Lok Sabha for giving hope to the Kabasura drinking water in the corona treatment. Recovery rate in tamilnadu from corona crossed 90%.